171 related articles for article (PubMed ID: 1864553)
41. [Technical aspects of autologous bone marrow transplantation].
Handgretinger R; Klingebiel T; Niethammer D
Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():39-41. PubMed ID: 7841779
[TBL] [Abstract][Full Text] [Related]
42. The value of long-term bone marrow cultures for the establishment of purging methods in bone marrow transplantation.
Schulze E
Acta Histochem Suppl; 1990; 39():489-95. PubMed ID: 2080292
[No Abstract] [Full Text] [Related]
43. Human herpes virus-6 infection in marrow graft recipients: role in pathogenesis of graft-versus-host disease. Newcastle upon Tyne Bone Marrow Transport Group.
Appleton AL; Sviland L; Peiris JS; Taylor CE; Wilkes J; Green MA; Pearson AD; Kelly PJ; Malcolm AJ; Proctor SJ
Bone Marrow Transplant; 1995 Dec; 16(6):777-82. PubMed ID: 8750269
[TBL] [Abstract][Full Text] [Related]
44. New developments in stem cell detection and stem cell selection in the context of autologous transplantations.
Douay L; Lopez M; Giarratana MC; Bony V; Bouchet S; Gorin NC
Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):87-9. PubMed ID: 8099734
[TBL] [Abstract][Full Text] [Related]
45. Lymphokine-activated killer (LAK) cell purging of leukemic bone marrow: range of activity against different hematopoietic neoplasms.
Long GS; Cramer DV; Harnaha JB; Hiserodt JC
Bone Marrow Transplant; 1990 Sep; 6(3):169-77. PubMed ID: 2252956
[TBL] [Abstract][Full Text] [Related]
46. Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow.
Elfenbein GJ; Sackstein R
Exp Hematol; 2004 Apr; 32(4):327-39. PubMed ID: 15050742
[TBL] [Abstract][Full Text] [Related]
47. Immunocytochemical detection of tumor cells in bone marrow and peripheral blood stem cell collections from patients with ovarian cancer.
Ross AA; Miller GW; Moss TJ; Kahn DG; Warner NE; Sweet DL; Louie KG; Schneidermann E; Pecora AL; Meagher RC
Bone Marrow Transplant; 1995 Jun; 15(6):929-33. PubMed ID: 7581093
[TBL] [Abstract][Full Text] [Related]
48. Human long-term bone marrow culture as a prognostic factor for hematopoietic reconstitution in autologous transplantation.
Gilabert R; Ayats R
Bone Marrow Transplant; 1994 May; 13(5):635-40. PubMed ID: 8054917
[TBL] [Abstract][Full Text] [Related]
49. Bone marrow-resident memory T cells survive pretransplant chemotherapy and contribute to early immune reconstitution of patients with acute myeloid leukemia given mafosfamide-purged autologous bone marrow transplantation.
Casorati G; Locatelli F; Pagani S; Garavaglia C; Montini E; Lisini D; Turin I; Rossi F; Dellabona P; Maccario R; Montagna D
Exp Hematol; 2005 Feb; 33(2):212-8. PubMed ID: 15676215
[TBL] [Abstract][Full Text] [Related]
50. Autologous bone marrow processing for autotransplantation using an automated cell processor and a semiautomated procedure.
Pierelli L; Menichella G; Serafini R; de Martini M; Paoloni A; Foddai ML; Scambia G; Benedetti Panici PL; Mancuso S; Leone G
Bone Marrow Transplant; 1991 May; 7(5):355-61. PubMed ID: 2070144
[TBL] [Abstract][Full Text] [Related]
51. Quantitative comparison of multiple myeloma tumor contamination in bone marrow harvest and leukapheresis autografts.
Vescio RA; Han EJ; Schiller GJ; Lee JC; Wu CH; Cao J; Shin J; Kim A; Lichtenstein AK; Berenson JR
Bone Marrow Transplant; 1996 Jul; 18(1):103-10. PubMed ID: 8832002
[TBL] [Abstract][Full Text] [Related]
52. Clonogenic leukemic progenitor cells in acute myelocytic leukemia are highly sensitive to cryopreservation: possible purging effect for autologous bone marrow transplantation.
Allieri MA; Lopez M; Douáy L; Mary JY; NGuyen L; Gorin NC
Bone Marrow Transplant; 1991 Feb; 7(2):101-5. PubMed ID: 2049553
[TBL] [Abstract][Full Text] [Related]
53. Cryopreservation of human bone marrow after purging T-cells or tumor cells.
Zhang ZX; Xu YJ; Chen Y; Li Y; Shen BF; Bai Y
Cryobiology; 1994 Oct; 31(5):478-82. PubMed ID: 7988157
[TBL] [Abstract][Full Text] [Related]
54. Immunomagnetic purging of breast cancer from bone marrow for autologous transplantation.
Shpall EJ; Bast RC; Joines WT; Jones RB; Anderson I; Johnston C; Eggleston S; Tepperberg M; Edwards S; Peters WP
Bone Marrow Transplant; 1991 Feb; 7(2):145-51. PubMed ID: 2049558
[TBL] [Abstract][Full Text] [Related]
55. [Experience with the use of different methods of bone marrow separation and cryopreservation at the bone marrow transplantation centers of the Regional Hospital of the City of Bolzano (Italy) and of the Saint Petersburg Institute of Hematology and Blood Transfusion].
Moiseev SI; Kozer P; Prinot O; Gentelini I; Gritsaev SV; Abdulkadyrov KM
Ter Arkh; 1994; 66(7):21-5. PubMed ID: 7985122
[No Abstract] [Full Text] [Related]
56. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides].
Sun J; Wu B; Liu Q; Feng R; Liu X; Meng F; Zhou S
Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):400-2. PubMed ID: 11877009
[TBL] [Abstract][Full Text] [Related]
57. [Viability and effectivness of deep cooled human bone marrow cells].
Mannheimer E
Wien Z Inn Med; 1970; 51(7):297-317. PubMed ID: 4108427
[No Abstract] [Full Text] [Related]
58. Ringed sideroblasts: a frequent observation after bone marrow transplantation.
Macon WR; Tham KT; Greer JP; Wolff SN
Mod Pathol; 1995 Sep; 8(7):782-5. PubMed ID: 8539238
[TBL] [Abstract][Full Text] [Related]
59. Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineering.
Webb IJ; Coral FS; Andersen JW; Elias AD; Finberg RW; Nadler LM; Ritz J; Anderson KC
Transfusion; 1996 Sep; 36(9):782-8. PubMed ID: 8823450
[TBL] [Abstract][Full Text] [Related]
60. [Behavior of the transplanted human bone marrow cells].
Zhukovskiĭ IIa; Orlova ZS; Niksanov ON
Ter Arkh; 1975; 47(6):64-9. PubMed ID: 1103341
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
